299 related articles for article (PubMed ID: 33535093)
61. New sequencing methodologies reveal interplay between multiple RNA-binding proteins and their RNAs.
Melamed S
Curr Genet; 2020 Aug; 66(4):713-717. PubMed ID: 32193580
[TBL] [Abstract][Full Text] [Related]
62. High-throughput screening for modulators of protein-protein interactions: use of photonic crystal biosensors and complementary technologies.
Heeres JT; Hergenrother PJ
Chem Soc Rev; 2011 Aug; 40(8):4398-410. PubMed ID: 21140010
[TBL] [Abstract][Full Text] [Related]
63. Epitranscriptomic technologies and analyses.
Li X; Liang QX; Lin JR; Peng J; Yang JH; Yi C; Yu Y; Zhang QC; Zhou KR
Sci China Life Sci; 2020 Apr; 63(4):501-515. PubMed ID: 32170629
[TBL] [Abstract][Full Text] [Related]
64. Cell permeable affinity- and activity-based probes.
Jones LH
Future Med Chem; 2015; 7(16):2131-41. PubMed ID: 26511518
[TBL] [Abstract][Full Text] [Related]
65. Review article: high-throughput affinity-based technologies for small-molecule drug discovery.
Zhu Z; Cuozzo J
J Biomol Screen; 2009 Dec; 14(10):1157-64. PubMed ID: 19822881
[TBL] [Abstract][Full Text] [Related]
66. High-throughput virtual screening using quantum mechanical probes: discovery of selective kinase inhibitors.
Zhou T; Caflisch A
ChemMedChem; 2010 Jul; 5(7):1007-14. PubMed ID: 20540063
[TBL] [Abstract][Full Text] [Related]
67. Discovery of the first small-molecule CsrA-RNA interaction inhibitors using biophysical screening technologies.
Maurer CK; Fruth M; Empting M; Avrutina O; Hoßmann J; Nadmid S; Gorges J; Herrmann J; Kazmaier U; Dersch P; Müller R; Hartmann RW
Future Med Chem; 2016 Jun; 8(9):931-47. PubMed ID: 27253623
[TBL] [Abstract][Full Text] [Related]
68. RNA Binding Protein as an Emerging Therapeutic Target for Cancer Prevention and Treatment.
Hong S
J Cancer Prev; 2017 Dec; 22(4):203-210. PubMed ID: 29302577
[TBL] [Abstract][Full Text] [Related]
69. Screening Library Design.
Ashenden SK
Methods Enzymol; 2018; 610():73-96. PubMed ID: 30390806
[TBL] [Abstract][Full Text] [Related]
70. Optimal HTS Fingerprint Definitions by Using a Desirability Function and a Genetic Algorithm.
Cortes Cabrera A; Petrone PM
J Chem Inf Model; 2018 Mar; 58(3):641-646. PubMed ID: 29425455
[TBL] [Abstract][Full Text] [Related]
71. Methyllysine binding domains: Structural insight and small molecule probe development.
Teske KA; Hadden MK
Eur J Med Chem; 2017 Aug; 136():14-35. PubMed ID: 28478342
[TBL] [Abstract][Full Text] [Related]
72. Fluorescence-based investigations of RNA-small molecule interactions.
McGovern-Gooch KR; Baird NJ
Methods; 2019 Sep; 167():54-65. PubMed ID: 31129289
[TBL] [Abstract][Full Text] [Related]
73. Ribonucleoprotein particles: advances and challenges in computational methods.
Dvir S; Argoetti A; Mandel-Gutfreund Y
Curr Opin Struct Biol; 2018 Dec; 53():124-130. PubMed ID: 30172766
[TBL] [Abstract][Full Text] [Related]
74. High-throughput screening with nucleosome substrate identifies small-molecule inhibitors of the human histone lysine methyltransferase NSD2.
Coussens NP; Kales SC; Henderson MJ; Lee OW; Horiuchi KY; Wang Y; Chen Q; Kuznetsova E; Wu J; Chakka S; Cheff DM; Cheng KC; Shinn P; Brimacombe KR; Shen M; Simeonov A; Lal-Nag M; Ma H; Jadhav A; Hall MD
J Biol Chem; 2018 Aug; 293(35):13750-13765. PubMed ID: 29945974
[TBL] [Abstract][Full Text] [Related]
75. Global Approaches in Studying RNA-Binding Protein Interaction Networks.
Sternburg EL; Karginov FV
Trends Biochem Sci; 2020 Jul; 45(7):593-603. PubMed ID: 32531229
[TBL] [Abstract][Full Text] [Related]
76. Discovery of novel scaffolds for Rho kinase 2 inhibitor through TRFRET-based high throughput screening assay.
Oh KS; Mun J; Cho JE; Lee S; Yi KY; Lim CJ; Lee JS; Park WJ; Lee BH
Comb Chem High Throughput Screen; 2013 Jan; 16(1):37-46. PubMed ID: 22934984
[TBL] [Abstract][Full Text] [Related]
77. Molecular fields in ligand discovery.
Gane PJ; Chan AW
Methods Mol Biol; 2013; 1008():479-99. PubMed ID: 23729264
[TBL] [Abstract][Full Text] [Related]
78. Matrix-screening reveals a vast potential for direct protein-protein interactions among RNA binding proteins.
Lang B; Yang JS; Garriga-Canut M; Speroni S; Aschern M; Gili M; Hoffmann T; Tartaglia GG; Maurer SP
Nucleic Acids Res; 2021 Jul; 49(12):6702-6721. PubMed ID: 34133714
[TBL] [Abstract][Full Text] [Related]
79. PAR-CliP--a method to identify transcriptome-wide the binding sites of RNA binding proteins.
Hafner M; Landthaler M; Burger L; Khorshid M; Hausser J; Berninger P; Rothballer A; Ascano M; Jungkamp AC; Munschauer M; Ulrich A; Wardle GS; Dewell S; Zavolan M; Tuschl T
J Vis Exp; 2010 Jul; (41):. PubMed ID: 20644507
[TBL] [Abstract][Full Text] [Related]
80. RNA-binding proteins in neurodegeneration: Seq and you shall receive.
Nussbacher JK; Batra R; Lagier-Tourenne C; Yeo GW
Trends Neurosci; 2015 Apr; 38(4):226-36. PubMed ID: 25765321
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
